Nycomed GmbH, Konstanz, Germany.
Bioorg Med Chem Lett. 2010 Dec 1;20(23):6998-7003. doi: 10.1016/j.bmcl.2010.09.119. Epub 2010 Sep 29.
A series of novel compound libraries inhibiting interleukin-2 inducible T cell kinase (ITK) were designed, synthesized and evaluated. In the first design cycle two library scaffolds were identified showing low micromolar inhibition of ITK. Further iterative design cycles including crystal structure information of ITK and structurally related kinases led to the identification of indolylindazole and indolylpyrazolopyridine compounds with low nanomolar ITK inhibition.
设计、合成并评估了一系列新型抑制白细胞介素-2 诱导的 T 细胞激酶(ITK)的化合物库。在第一轮设计中,确定了两种库支架,对 ITK 的抑制作用为低微摩尔。进一步的迭代设计循环包括 ITK 和结构相关激酶的晶体结构信息,导致了低纳摩尔 ITK 抑制作用的吲哚吲唑和吲哚吡唑吡啶化合物的鉴定。